Gosse J Adema

23PUBLICATIONS
74CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 11, 2026
Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration.

|Apr 03, 2026
Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity.

Jesper van Eck van der Sluijs, Anne H C Valk, Eline J H van Houtum

|Mar 25, 2026
In Vivo Analysis of Neuroblastoma Targeting Potential of aGD2-SIRPα Fusion Antibodies for Local CD47 Blockade.

Fabian Schuurmans, Matthia G M Boros, Renske J E van den Bijgaart

|Jan 16, 2026
The radiotherapy induced cyclic GMP-AMP-synthase re-localization and immune signature predicts HNSCC treatment efficacy.

Vera E Mekers, Paul N Span, Maaike Looman

|Oct 07, 2025
Development of aGD2-SIRPα Fusion Antibodies Targeting Neuroblastoma and the Innate Immune Checkpoint Receptor CD47.

Fabian Schuurmans, Anja Wittner, Renske J E van den Bijgaart

|Feb 03, 2025
Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment Efficacy.

Anne P M Beerkens, Sandra Heskamp, Flavia V Reinema

Pageof 4

Frequent Collaborators

5 joint publications

Lenneke Am Cornelissen

3 joint publications

Eline Jh van Houtum

3 joint publications

Lune van den Boogaard

3 joint publications

Jesper van Eck van der Sluijs